Search

Randall L. Beane

Examiner (ID: 7309, Phone: (571)270-3457 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1675, 1654
Total Applications
588
Issued Applications
169
Pending Applications
127
Abandoned Applications
335

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18953736 [patent_doc_number] => 20240042063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => LINKED AND OTHER pH-TRIGGERED COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/331904 [patent_app_country] => US [patent_app_date] => 2023-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57180 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18331904 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/331904
LINKED AND OTHER pH-TRIGGERED COMPOUNDS Jun 7, 2023 Abandoned
Array ( [id] => 19003624 [patent_doc_number] => 20240067695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-29 [patent_title] => GLUCAGON-LIKE PEPTIDE-2 COMPOSITIONS AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 18/330032 [patent_app_country] => US [patent_app_date] => 2023-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 81624 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18330032 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/330032
GLUCAGON-LIKE PEPTIDE-2 COMPOSITIONS AND METHODS OF MAKING AND USING SAME Jun 5, 2023 Abandoned
Array ( [id] => 18725795 [patent_doc_number] => 20230340013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => POLYPEPTIDES AND METHODS [patent_app_type] => utility [patent_app_number] => 18/198205 [patent_app_country] => US [patent_app_date] => 2023-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18198205 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/198205
POLYPEPTIDES AND METHODS May 15, 2023 Abandoned
Array ( [id] => 18725795 [patent_doc_number] => 20230340013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => POLYPEPTIDES AND METHODS [patent_app_type] => utility [patent_app_number] => 18/198205 [patent_app_country] => US [patent_app_date] => 2023-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18198205 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/198205
POLYPEPTIDES AND METHODS May 15, 2023 Abandoned
Array ( [id] => 18725795 [patent_doc_number] => 20230340013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => POLYPEPTIDES AND METHODS [patent_app_type] => utility [patent_app_number] => 18/198205 [patent_app_country] => US [patent_app_date] => 2023-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18198205 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/198205
POLYPEPTIDES AND METHODS May 15, 2023 Abandoned
Array ( [id] => 18939615 [patent_doc_number] => 20240034754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-01 [patent_title] => ENZYMATIC BIOCIDE FOR REMOVAL OF FOODBORNE MICROBIAL CONTAMINATION [patent_app_type] => utility [patent_app_number] => 18/314035 [patent_app_country] => US [patent_app_date] => 2023-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18314035 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/314035
ENZYMATIC BIOCIDE FOR REMOVAL OF FOODBORNE MICROBIAL CONTAMINATION May 7, 2023 Pending
Array ( [id] => 18709183 [patent_doc_number] => 20230331795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => ENGINEERING IMMUNE CHECKPOINT BLOCKADE NANOBODY-STING DELTA-TM FUSION PROTEIN AS A VERSATILE TREATMENT FOR SOLID TUMOR CANCERS [patent_app_type] => utility [patent_app_number] => 18/312030 [patent_app_country] => US [patent_app_date] => 2023-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15032 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18312030 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/312030
ENGINEERING IMMUNE CHECKPOINT BLOCKADE NANOBODY-STING DELTA-TM FUSION PROTEIN AS A VERSATILE TREATMENT FOR SOLID TUMOR CANCERS May 3, 2023 Pending
Array ( [id] => 18709183 [patent_doc_number] => 20230331795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => ENGINEERING IMMUNE CHECKPOINT BLOCKADE NANOBODY-STING DELTA-TM FUSION PROTEIN AS A VERSATILE TREATMENT FOR SOLID TUMOR CANCERS [patent_app_type] => utility [patent_app_number] => 18/312030 [patent_app_country] => US [patent_app_date] => 2023-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15032 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18312030 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/312030
ENGINEERING IMMUNE CHECKPOINT BLOCKADE NANOBODY-STING DELTA-TM FUSION PROTEIN AS A VERSATILE TREATMENT FOR SOLID TUMOR CANCERS May 3, 2023 Pending
Array ( [id] => 18692632 [patent_doc_number] => 20230322951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => Bi-Specific Fusion Proteins [patent_app_type] => utility [patent_app_number] => 18/311306 [patent_app_country] => US [patent_app_date] => 2023-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14077 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18311306 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/311306
Bi-Specific Fusion Proteins May 2, 2023 Pending
Array ( [id] => 19418451 [patent_doc_number] => 20240294574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => STABILIZED PEPTIDES FOR COVALENT BINDING TO TARGET PROTEIN [patent_app_type] => utility [patent_app_number] => 18/306724 [patent_app_country] => US [patent_app_date] => 2023-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24679 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18306724 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/306724
STABILIZED PEPTIDES FOR COVALENT BINDING TO TARGET PROTEIN Apr 24, 2023 Pending
Array ( [id] => 18879071 [patent_doc_number] => 20240002440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS [patent_app_type] => utility [patent_app_number] => 18/186292 [patent_app_country] => US [patent_app_date] => 2023-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31314 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18186292 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/186292
AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS Mar 19, 2023 Pending
Array ( [id] => 19049346 [patent_doc_number] => 20240091315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME [patent_app_type] => utility [patent_app_number] => 18/182954 [patent_app_country] => US [patent_app_date] => 2023-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 135764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18182954 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/182954
XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME Mar 12, 2023 Pending
Array ( [id] => 18737852 [patent_doc_number] => 20230346752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING [patent_app_type] => utility [patent_app_number] => 18/181487 [patent_app_country] => US [patent_app_date] => 2023-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22191 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181487 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/181487
PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING Mar 8, 2023 Pending
Array ( [id] => 18567099 [patent_doc_number] => 20230257428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES [patent_app_type] => utility [patent_app_number] => 18/160954 [patent_app_country] => US [patent_app_date] => 2023-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63182 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 262 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160954 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/160954
METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES Jan 26, 2023 Abandoned
Array ( [id] => 18567099 [patent_doc_number] => 20230257428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES [patent_app_type] => utility [patent_app_number] => 18/160954 [patent_app_country] => US [patent_app_date] => 2023-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63182 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 262 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160954 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/160954
METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES Jan 26, 2023 Abandoned
Array ( [id] => 18374435 [patent_doc_number] => 20230149514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => CROSSLINKED PARTICLES, COMPOSITION COMPRISING THE CROSSLINKED PARTICLES, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD OF TREATING AN INFECTION [patent_app_type] => utility [patent_app_number] => 18/099378 [patent_app_country] => US [patent_app_date] => 2023-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8122 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18099378 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/099378
CROSSLINKED PARTICLES, COMPOSITION COMPRISING THE CROSSLINKED PARTICLES, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD OF TREATING AN INFECTION Jan 19, 2023 Abandoned
Array ( [id] => 18970442 [patent_doc_number] => 20240050534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => USE OF COLLAGEN COMPOSITIONS FOR INCREASING TELOMERE LENGTH [patent_app_type] => utility [patent_app_number] => 18/096941 [patent_app_country] => US [patent_app_date] => 2023-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9518 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096941 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/096941
USE OF COLLAGEN COMPOSITIONS FOR INCREASING TELOMERE LENGTH Jan 12, 2023 Abandoned
Array ( [id] => 18970442 [patent_doc_number] => 20240050534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => USE OF COLLAGEN COMPOSITIONS FOR INCREASING TELOMERE LENGTH [patent_app_type] => utility [patent_app_number] => 18/096941 [patent_app_country] => US [patent_app_date] => 2023-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9518 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096941 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/096941
USE OF COLLAGEN COMPOSITIONS FOR INCREASING TELOMERE LENGTH Jan 12, 2023 Abandoned
Array ( [id] => 18366686 [patent_doc_number] => 20230148277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => DISULFIDE BOND CONTAINING COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/093509 [patent_app_country] => US [patent_app_date] => 2023-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17619 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18093509 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/093509
DISULFIDE BOND CONTAINING COMPOUNDS AND USES THEREOF Jan 4, 2023 Abandoned
Array ( [id] => 18716538 [patent_doc_number] => 11793861 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => PTH prodrugs [patent_app_type] => utility [patent_app_number] => 18/053693 [patent_app_country] => US [patent_app_date] => 2022-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34961 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053693 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/053693
PTH prodrugs Nov 7, 2022 Issued
Menu